Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robinhood - New Portfolio
Mark Sheppard
RobinhoodIndividual Investor
Ranked #377,875 out of 769,291 TipRanks' Investors
Success Rate
28 out of 62
profitable transactions
profitable transactions
Average Return
10.88%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 4.92%
6-Month Return-
12-Month Return-
YTD Return▲ 6.04%
Total Return▲ 6.04%
Best Trade
Bio
Performance
37.60%0-37.60%
▼ 12.40%
▼ 4.03%
―
Apr 2024
▲ 11.46%
▲ 5.06%
―
May 2024
▼ 2.25%
▲ 3.53%
―
Jun 2024
▲ 25.72%
▲ 1.21%
▼ 4.84%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 6.95%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 0.08%
Sep 2024
▲ 5.70%
▼ 0.89%
▲ 4.11%
Oct 2024
▲ 37.60%
▲ 4.40%
▲ 14.94%
Nov 2024
▼ 12.40%▼ 4.03%―
▲ 11.46%▲ 5.06%―
▼ 2.25%▲ 3.53%―
▲ 25.72%▲ 1.21%▼ 4.84%
▼ 4.22%▲ 2.34%▼ 6.95%
▲ 7.82%▲ 2.10%▲ 0.08%
▲ 5.70%▼ 0.89%▲ 4.11%
▲ 37.60%▲ 4.40%▲ 14.94%
Recent Activity
Mind Medicine
―
▼ 8.26%
3
Close
Nov 16, 2024
Tesla
3.89%
▲ 1.73%
5
Buy
Nov 15, 2024
Viking Therapeutics
―
▼ 9.68%
5
Close
Nov 15, 2024
ChainLink
3.47%
▲ 10.65%
4
Buy
Nov 12, 2024
SoundHound AI, Inc Class A
5.92%
▲ 16.12%
3
Buy
Nov 12, 2024
Amazon
―
▼ 1.99%
4
Close
Nov 11, 2024
Direxion Daily Semiconductor Bull 3x Shares
―
▼ 26.32%
5
Close
Nov 11, 2024
Tenaya Therapeutics
0.79%
▼ 21.74%
1
Open
Nov 08, 2024
Jasper Therapeutics
―
▲ 12.35%
4
Close
Nov 07, 2024
Skye Bioscience
0.79%
▼ 7.16%
4
Buy
Nov 07, 2024
Tevogen Bio Holdings
―
▼ 46.23%
4
Close
Nov 07, 2024
AGNC Investment
―
▼ 9.48%
2
Close
Nov 04, 2024
COMPASS Pathways
―
▼ 36.33%
2
Close
Nov 01, 2024
Super Micro Computer
―
▼ 9.17%
6
Close
Nov 01, 2024
BioVie
―
▲ 2.32%
3
Close
Nov 01, 2024
Arcturus Therapeutics
―
▼ 19.39%
4
Close
Oct 30, 2024
Nukkleus
―
▲ 852.38%
2
Close
Oct 25, 2024
YieldMax TSLA Option Income Strategy ETF
3.46%
▲ 43.25%
1
Open
Oct 23, 2024
YieldMax NVDA Option Income Strategy ETF
4.25%
▲ 13.17%
4
Buy
Oct 22, 2024
Inozyme Pharma
―
▲ 9.81%
2
Close
Oct 17, 2024